Heron Therapeutics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Heron Therapeutics Inc 公司

Heron Therapeutics, Inc. 是一家商业阶段的生物技术公司。该公司将一系列产品商业化，用于护理急性护理和肿瘤患者。其肿瘤护理产品组合包括 SUSTOL 和 CINVANTI。SUSTOL 用于预防与中度致吐化疗 (MEC) 以及蒽环类和环磷酰胺 (AC) 联合化疗方案相关的急性和延迟性恶心和呕吐。CINVANTI 是阿瑞吡坦的静脉 (IV) 制剂，阿瑞吡坦是一种 P 物质/神经激肽-1 (NK1) 受体拮抗剂。其急性护理产品组合包括 ZYNRELEF 和 APONVIE。HTX- ZYNRELEF 是一种双作用局部麻醉剂，可提供局部麻醉剂布比卡因和低剂量非甾体抗炎药美洛昔康的固定剂量组合。 APONVIE 是一种 NK1 受体拮抗剂的静脉注射剂型，用于治疗术后恶心呕吐 (PONV)。其产品在美国销售。

Heron Therapeutics Inc简介



公司代码HRTX

公司名称Heron Therapeutics Inc

上市日期Aug 26, 1987

CEOMr. Craig Alexander Collard

员工数量122

证券类型Ordinary Share

年结日Aug 26

公司地址100 Regency Forest Drive

城市CARY

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编27518

电话18582514400

网址https://www.herontx.com/

公司代码HRTX

上市日期Aug 26, 1987

CEOMr. Craig Alexander Collard

Heron Therapeutics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Craig Alexander Collard

Chief Executive Officer, Director

504.19K

+10.66%

Ms. Ira Duarte

Chief Financial Officer, Executive Vice President

179.79K

+9.48%

Dr. William P. (Bill) Forbes

Executive Vice President, Chief Development Officer

166.20K

+10.33%

Dr. Sharmila Dissanaike, M.D.

Independent Director

68.45K

-3.44%

Mr. Christian Waage

Independent Director

66.18K

+26.70%

Mr. Craig A. Johnson

Lead Independent Director

65.82K

-5.73%

Mr. Adam Morgan

Chairman of the Board

32.89K

+19.94%

Mr. Michael Kaseta

Independent Director

2.37K

-95.76%

Mr. Mark Hensley

Chief Operating Officer, Executive Vice President

--

Mr. Tom Cusack ,

Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Craig Alexander Collard

Chief Executive Officer, Director

504.19K

+10.66%

Ms. Ira Duarte

Chief Financial Officer, Executive Vice President

179.79K

+9.48%

Dr. William P. (Bill) Forbes

Executive Vice President, Chief Development Officer

166.20K

+10.33%

Dr. Sharmila Dissanaike, M.D.

Independent Director

68.45K

-3.44%

Mr. Christian Waage

Independent Director

66.18K

+26.70%

Mr. Craig A. Johnson

Lead Independent Director

65.82K

-5.73%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

业务USD

名称

营收

占比

CINVANTI

24.14M

64.90%

ZYNRELEF

8.19M

22.01%

APONVIE

2.46M

6.62%

SUSTOL

2.40M

6.46%

地区USD

名称

营收

占比

United States

37.20M

100.00%

业务

地区

业务USD

名称

营收

占比

CINVANTI

24.14M

64.90%

ZYNRELEF

8.19M

22.01%

APONVIE

2.46M

6.62%

SUSTOL

2.40M

6.46%

股东统计

更新时间: 11月1日周六

持股股东

股东类型

持股股东

占比

Rubric Capital Management LP

16.39%

BlackRock Institutional Trust Company, N.A.

4.98%

The Vanguard Group, Inc.

4.61%

Adage Capital Management, L.P.

4.28%

Velan Capital Investment Management LP

3.81%

其他

65.93%

持股股东

占比

Rubric Capital Management LP

16.39%

BlackRock Institutional Trust Company, N.A.

4.98%

The Vanguard Group, Inc.

4.61%

Adage Capital Management, L.P.

4.28%

Velan Capital Investment Management LP

3.81%

其他

65.93%

股东类型

持股股东

占比

Hedge Fund

29.63%

Investment Advisor

23.40%

Investment Advisor/Hedge Fund

15.44%

Research Firm

3.63%

Pension Fund

1.42%

Individual Investor

0.60%

Bank and Trust

0.12%

Insurance Company

0.03%

其他

25.72%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

339

134.06M

76.24%

-19.84M

2025Q2

352

128.42M

84.17%

-20.15M

2025Q1

384

126.94M

83.22%

-22.20M

2024Q4

390

118.52M

78.10%

-45.51M

2024Q3

400

125.21M

82.85%

-42.71M

2024Q2

402

132.96M

88.55%

-36.75M

2024Q1

402

122.65M

81.87%

-45.18M

2023Q4

413

115.58M

77.36%

-37.11M

2023Q3

417

122.12M

87.17%

-25.94M

2023Q2

428

102.54M

85.75%

-39.37M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Rubric Capital Management LP

29.10M

15.87%

+2.39M

+8.94%

Aug 08, 2025

BlackRock Institutional Trust Company, N.A.

9.13M

4.98%

+1.33M

+17.12%

Jun 30, 2025

The Vanguard Group, Inc.

8.47M

4.62%

+245.88K

+2.99%

Jun 30, 2025

Adage Capital Management, L.P.

7.85M

4.28%

--

Jun 30, 2025

Velan Capital Investment Management LP

6.99M

3.81%

--

Jun 30, 2025

Palisade Capital Management, LLC

5.09M

2.77%

-200.03K

-3.78%

Jun 30, 2025

Tejara Capital Ltd.

4.52M

2.46%

-59.99K

-1.31%

Jun 30, 2025

Geode Capital Management, L.L.C.

3.57M

1.95%

+453.08K

+14.55%

Jun 30, 2025

State Street Investment Management (US)

3.46M

1.89%

+208.36K

+6.40%

Jun 30, 2025

D. E. Shaw & Co., L.P.

3.20M

1.75%

+214.10K

+7.17%

Jun 30, 2025

持股ETF



更新时间: 11月2日周日

机构名称

占比

Invesco NASDAQ Future Gen 200 ETF

0.45%

iShares Micro-Cap ETF

0.04%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

Global X Russell 2000 ETF

0.01%

ProShares Hedge Replication ETF

0.01%

iShares Russell 2000 ETF

0.01%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.01%

iShares Russell 2000 Value ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

占比0.45%

iShares Micro-Cap ETF

占比0.04%

Invesco RAFI US 1500 Small-Mid ETF

占比0.01%

Schwab U.S. Small-Cap ETF

占比0.01%

Global X Russell 2000 ETF

占比0.01%

ProShares Hedge Replication ETF

占比0.01%

iShares Russell 2000 ETF

占比0.01%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.01%

iShares Russell 2000 Value ETF

占比0.01%

ProShares UltraPro Russell2000

占比0.01%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据